News

Newseria BIZNES12d
New Antibody Arrays by Creative Biolabs Boost Immune Signaling Research
Creative Biolabs recently updated its antibody chip platform, expanding product arrays for phosphorylation signaling and ...
AZoLifeSciences on MSN9d
Study Identifies SMARCB1 and MEOX2 Genes as Growth Regulators of Lung Cancers
A Cancer Gene Therapy study reveals that MEOX2 promotes lung cancer progression while SMARCB1 acts as a tumor suppressor, ...
AlphaGalileo3d
EGFR inhibitor-linked cytokine storms: study uncovers the trigger
In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...
News-Medical.Net on MSN12d
New insights reveal EGFR as a target in KRAS-mutated colon cancer
KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.
ascopubs.org20d
Mutations within the EGFR signaling pathway: Influence on efficacy in FIRE-3—A randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for ...
PET scan as a prognostic marker in advanced colorectal cancer. This is an ASCO Meeting Abstract from the 2014 Gastrointestinal Cancers Symposium. This abstract does not include a full text component.
AHA/ASA Journals2d
High Dietary Phosphate Intake Induces Hypertension and Sympathetic Overactivation Through Central Fibroblast Growth Factor Receptor Signaling
BACKGROUND: Recent studies have highlighted the deleterious role of high phosphate intake in hypertension by means of ...
ascopubs.org28d
Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).
NEJ026: Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations. This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...